Intellia Therapeutics (NTLA) Non-cash Items (2016 - 2026)

Intellia Therapeutics has reported Non-cash Items over the past 11 years, most recently at $2.5 million for Q1 2026.

  • Quarterly Non-cash Items rose 12185.0% to $2.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Mar 2026, up 12185.0% year-over-year, with the annual reading at $4.1 million for FY2025, 3.63% down from the prior year.
  • Non-cash Items was $2.5 million for Q1 2026 at Intellia Therapeutics, up from $50000.0 in the prior quarter.
  • Over five years, Non-cash Items peaked at $204.9 million in Q1 2022 and troughed at $20000.0 in Q1 2025.
  • The 5-year median for Non-cash Items is $4.2 million (2025), against an average of $38.7 million.
  • Year-over-year, Non-cash Items crashed 99.93% in 2025 and then soared 12185.0% in 2026.
  • A 5-year view of Non-cash Items shows it stood at $3.2 million in 2022, then skyrocketed by 1016.73% to $35.9 million in 2023, then crashed by 99.03% to $350000.0 in 2024, then crashed by 85.71% to $50000.0 in 2025, then soared by 4814.0% to $2.5 million in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Non-cash Items are $2.5 million (Q1 2026), $50000.0 (Q4 2025), and $4.1 million (Q3 2025).